Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Afshin Zariri & Peter van der Ley. (2015) Biosynthetically engineered lipopolysaccharide as vaccine adjuvant. Expert Review of Vaccines 14:6, pages 861-876.
Read now
Read now
Shih-shiung Huang, I-Hsun Li, Po-da Hong & Ming-kung Yeh. (2014) Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague. International Journal of Nanomedicine 9, pages 813-822.
Read now
Read now
Guang Tian, Zhizhen Qi, Yefeng Qiu, Xiaohong Wu, Qingwen Zhang, Xiaoyan Yang, Youquan Xin, Jian He, Yujing Bi, Qiong Wang, Jiyuan Zhou, Yanxiao Fan, Yazhou Zhou, Yongqiang Jiang, Ruifu Yang & Xiaoyi Wang. (2014) Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta. Human Vaccines & Immunotherapeutics 10:12, pages 3552-3560.
Read now
Read now
Articles from other publishers (34)
Xuan OuYang, Xican Xu, Qingqing Qin, Chenxi Dai, Hongyu Wang, Shuang Liu, Lingfei Hu, Xiaolu Xiong, Huiyu Liu & Dongsheng Zhou. (2023) Manganese‐Based Nanoparticle Vaccine for Combating Fatal Bacterial Pneumonia. Advanced Materials.
Crossref
Crossref
E. Diane Williamson & Petra C.F. Oyston. 2023. Plotkin's Vaccines. Plotkin's Vaccines
816
825.e4
.
Theresa J. Ochoa & Miguel O’Ryan. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
864
869.e2
.
Sahar Sabour, Taher Azimi, Ahmad Nasser, Nahal Hadi, Amin Mohsenzadeh & Aref Shariati. (2022) A global overview of the most important zoonotic bacteria pathogens transmitted from Rattus norvegicus to humans in urban environments. Infectious Medicine 1:3, pages 192-207.
Crossref
Crossref
Nabendu Debnath, Mony Thakur, Khushboo, Neelam P. Negi, Vibhav Gautam, Ashok Yadav & Deepak Kumar. (2021) Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges. Biotechnology and Bioengineering 119:2, pages 327-346.
Crossref
Crossref
Wei Zhang, Xiaolin Song, Lina Zhai, Jianshu Guo, Xinying Zheng, Lili Zhang, Meng Lv, Lingfei Hu, Dongsheng Zhou, Xiaolu Xiong & Wenhui Yang. (2022) Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation. Frontiers in Immunology 13.
Crossref
Crossref
Barry D. Moore, Clair Macleod, Lisa Henning, Robert Krile, Ying-Liang Chou, Thomas R. Laws, Wendy A. Butcher, Kristoffer M. Moore, Nicola J. Walker, Ethel Diane Williamson & Darrell R. Galloway. (2022) Predictors of Survival after Vaccination in a Pneumonic Plague Model. Vaccines 10:2, pages 145.
Crossref
Crossref
Sakineh Pirahmadi, Shima Afzali, Mostafa Zargar, Sedigheh Zakeri & Akram Abouie Mehrizi. (2021) How can we develop an effective subunit vaccine to achieve successful malaria eradication?. Microbial Pathogenesis 160, pages 105203.
Crossref
Crossref
Raysa Rosario-Acevedo, Sergei S. Biryukov, Joel A. Bozue & Christopher K. Cote. (2021) Plague Prevention and Therapy: Perspectives on Current and Future Strategies. Biomedicines 9:10, pages 1421.
Crossref
Crossref
Jason A. Rosenzweig, Emily K. Hendrix & Ashok K. Chopra. (2021) Plague vaccines: new developments in an ongoing search. Applied Microbiology and Biotechnology 105:12, pages 4931-4941.
Crossref
Crossref
Christina D'Arco, Alison A. McCormick & Paul M. Arnaboldi. (2021) Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection. Vaccine 39:9, pages 1435-1444.
Crossref
Crossref
Christopher K. Cote, Sergei S. Biryukov, Christopher P. Klimko, Jennifer L. Shoe, Melissa Hunter, Raysa Rosario-Acevedo, David P. Fetterer, Krishna L. Moody, Joshua R. Meyer, Nathaniel O. Rill, Jennifer L. Dankmeyer, Patricia L. Worsham, Joel A. Bozue & Susan L. Welkos. (2021) Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis. Vaccines 9:2, pages 161.
Crossref
Crossref
Andrey A. Byvalov, Ilya V. Konyshev, Vladimir N. Uversky, Svetlana V. Dentovskaya & Andrey P. Anisimov. (2020) Yersinia Outer Membrane Vesicles as Potential Vaccine Candidates in Protecting against Plague. Biomolecules 10:12, pages 1694.
Crossref
Crossref
Junxia Feng, Yingying Deng, Mengjiao Fu, Xueyuan Hu, Wenbo Luo, Zhiyu Lu, Lupeng Dai, Huiying Yang, Xiaodong Zhao, Zongmin Du, Bohai Wen, Lingxiao Jiang, Dongsheng Zhou, Jun Jiao & Xiaolu Xiong. (2020) Construction of a Live-Attenuated Vaccine Strain of Yersinia pestis EV76-B-SHUΔpla and Evaluation of Its Protection Efficacy in a Mouse Model by Aerosolized Intratracheal Inoculation. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Ankit Gupta, Bineet Narayan, Subodh Kumar & Shailendra Kumar Verma. (2020) Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis. Frontiers in Immunology 11.
Crossref
Crossref
Vrinda M Kurup & Jaya Thomas. (2019) Edible Vaccines: Promises and Challenges. Molecular Biotechnology 62:2, pages 79-90.
Crossref
Crossref
William Bowen, Lalit Batra, Amanda R. Pulsifer, Esma S. Yolcu, Matthew B. Lawrenz & Haval Shirwan. (2019) Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Vaccine 37:38, pages 5708-5716.
Crossref
Crossref
Zaurbek Sagiyev, Almas Berdibekov, Tatyana Bolger, Almagul Merekenova, Svetlana Ashirova, Zamir Nurgozhin & Zhandos Dalibayev. (2019) Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015. PLOS ONE 14:6, pages e0218366.
Crossref
Crossref
Susan D. JonesBakyt AtshabarBoris V. Schmid, Marlene ZukAnna AmraminaNils Chr. Stenseth. (2019) Living with plague: Lessons from the Soviet Union’s antiplague system. Proceedings of the National Academy of Sciences 116:19, pages 9155-9163.
Crossref
Crossref
E. Criscuolo, V. Caputo, R. A. Diotti, G. A. Sautto, G. A. Kirchenbaum & N. Clementi. (2019) Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines. Journal of Immunology Research 2019, pages 1-13.
Crossref
Crossref
Wei Sun & Amit K. Singh. (2019) Plague vaccine: recent progress and prospects. npj Vaccines 4:1.
Crossref
Crossref
S. E. Gostishcheva, N. V. Abzaeva, G. F. Ivanova, D. V. Rostovtseva, L. S. Katunina & A. A. Zuenko. (2018) Quality Assessment of the Live Plague Vaccine Prepared Using nutrient Medium on the Basis of Hydrolysate of Concentrated Corn steep. Problems of Particularly Dangerous Infections:3, pages 46-49.
Crossref
Crossref
Li Liu, Dong Wei, Zhe Qu, Li Sun, Yufa Miao, Yanwei Yang, Jinbiao Lu, Weixin Du, Bingxiang Wang & Bo Li. (2018) A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques. Journal of Applied Toxicology 38:3, pages 408-417.
Crossref
Crossref
Young-Hwa Kim, Pil-Gu Park, Sang-Hwan Seo, Kee-Jong Hong & Hyewon Youn. (2018)
Development of dual reporter imaging system for
Francisella tularensis
to monitor the spatio-temporal pathogenesis and vaccine efficacy
. Clinical and Experimental Vaccine Research 7:2, pages 129.
Crossref
Crossref
Ruifu Yang. (2018) Plague: Recognition, Treatment, and Prevention. Journal of Clinical Microbiology 56:1.
Crossref
Crossref
Theresa J. Ochoa & Miguel O’Ryan. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
846
851.e1
.
Yujing Bi & Xiaoyi Wang. 2018. Yersinia Pestis Protocols. Yersinia Pestis Protocols
231
236
.
Ruifeng Mao, Dongli Wu & Yefu Wang. (2016) Surface display on lactic acid bacteria without genetic modification: strategies and applications. Applied Microbiology and Biotechnology 100:22, pages 9407-9421.
Crossref
Crossref
Miao Wang, Zeqian Gao, Yongguang Zhang & Li Pan. (2016) Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Applied Microbiology and Biotechnology 100:13, pages 5691-5701.
Crossref
Crossref
Ruifu Yang, Yujun Cui & Yujing Bi. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective
377
391
.
Valentina A. Feodorova, Lidiya V. Sayapina & Vladimir L. Motin. 2016. Vaccine Design. Vaccine Design
487
498
.
Wei Sun, Shilpa Sanapala, Jeremy C. Henderson, Shandiin Sam, Joseph Olinzock, M. Stephen Trent & Roy CurtissIIIIII. (2014) LcrV Delivered via Type III Secretion System of Live Attenuated Yersinia pseudotuberculosis Enhances Immunogenicity against Pneumonic Plague. Infection and Immunity 82:10, pages 4390-4404.
Crossref
Crossref
Yujun Cui, Xianwei Yang, Xiao Xiao, Andrey P. Anisimov, Dongfang Li, Yanfeng Yan, Dongsheng Zhou, Minoarisoa Rajerison, Elisabeth Carniel, Mark Achtman, Ruifu Yang & Yajun Song. (2014) Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infection, Genetics and Evolution 26, pages 172-179.
Crossref
Crossref
Ayelet Zauberman, Yehuda Flashner, Yinon Levy, Yaron Vagima, Avital Tidhar, Ofer Cohen, Erez Bar-Haim, David Gur, Moshe Aftalion, Gideon Halperin, Avigdor Shafferman & Emanuelle Mamroud. (2013) YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. PLoS ONE 8:12, pages e83560.
Crossref
Crossref